Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis

Citation
F. Santini et al., Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis, J CLIN END, 84(2), 1999, pp. 493-498
Citations number
39
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
84
Issue
2
Year of publication
1999
Pages
493 - 498
Database
ISI
SICI code
0021-972X(199902)84:2<493:SIITHF>2.0.ZU;2-B
Abstract
The pattern of circulating iodothyronines in the fetus differs from that in the adult, being characterized by low levels of serum T-3. In this study, concentrations of various iodothyronines were measured in sera from neonate s of various postconceptional age (PA). Results obtained in cord sera at bi rth (PA, 24-40 weeks), reflecting the fetal pattern, were compared with tho se found during extrauterine life in newborns of 5 days or more of postnata l life (PA, 27-46 weeks). The main findings are: Starting at 30 weeks of PA , serum levels increase linearly during extrauterine life; and at 40 weeks, they are more than 200% of those measured in cord sera from newborns of eq uivalent PA. Serum reverse T-3 (rT3) levels during fetal life are higher th an those measured during extrauterine life; but they significantly decrease , starting at 30 weeks of PA. Serum T-3 sulfate (T3S) does not significantl y differ between the two groups, showing the highest values at 28-30 weeks of PA, and significantly decreasing at 30-40 weeks. T3S levels are directly correlated with rT3, both in fetal and extrauterine life, whereas a signif icant negative correlation between T3S and T-3 is found only during extraut erine life. In conclusion: 1) changes in serum concentrations of iodothyron ines in umbilical cord and during postnatal life indicate that maturation o f extrathyroidal type I-iodothyronine monodeiodinase (MD) accelerates, star ting at 30 weeks of PA; 2) high levels of type III-MD activity in fetal tis sues prevent the rise of serum T-3, whereas they maintain high levels of rT 3 during intrauterine life; 3) an important mechanism leading to the transi tion from the fetal to the postnatal thyroid hormone balance is a sudden de crease in type III-MD activity; iv) because placenta contains a high amount of type III-MD, it is conceivable that placenta contributes to maintain lo w T-3 and high rT3 serum concentrations during fetal Life and that its remo val at birth is responsible for most changes in iodothyronine metabolism oc curring afterwards.